Literature DB >> 26810501

[Preventing post solid organ transplant tuberculosis with antibiotic prophylaxis].

L Schneidewind1, S Schmidt2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26810501     DOI： 10.1007/s00120-015-0022-0

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


× No keyword cloud information.
  8 in total

1.  A double-blind randomized controlled trial of primary isoniazid prophylaxis in dialysis and transplant patients.

Authors:  G T John; P P Thomas; M Thomas; L Jeyaseelan; C K Jacob; J C Shastry
Journal:  Transplantation       Date:  1994-06-15       Impact factor: 4.939

Review 2.  [Infections after kidney transplantation].

Authors:  Iva Svobodová; Eva Honsová
Journal:  Cesk Patol       Date:  2015

3.  Isoniazid prophylaxis in lung transplantation.

Authors:  A Roman; C Bravo; G Levy; V Monforte; R Vidal; J Solé; J Maestre; F Morell
Journal:  J Heart Lung Transplant       Date:  2000-09       Impact factor: 10.247

4.  Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management.

Authors:  N Singh; D L Paterson
Journal:  Clin Infect Dis       Date:  1998-11       Impact factor: 9.079

5.  Use of isoniazid chemoprophylaxis in renal transplant recipients.

Authors:  Rubina Naqvi; Anwar Naqvi; Sohail Akhtar; Ejaz Ahmed; Huma Noor; Tahir Saeed; Fazal Akhtar; Adib Rizvi
Journal:  Nephrol Dial Transplant       Date:  2009-09-25       Impact factor: 5.992

6.  European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.7.2. Late infections. Tuberculosis.

Authors: 
Journal:  Nephrol Dial Transplant       Date:  2002       Impact factor: 5.992

7.  Challenge of tuberculosis in renal transplantation.

Authors:  K K Malhotra
Journal:  Transplant Proc       Date:  2007-04       Impact factor: 1.066

8.  Urine Injury Biomarkers and Risk of Adverse Outcomes in Recipients of Prevalent Kidney Transplants: The Folic Acid for Vascular Outcome Reduction in Transplantation Trial.

Authors:  Nisha Bansal; Myra A Carpenter; Daniel E Weiner; Andrew S Levey; Marc Pfeffer; John W Kusek; Jianwen Cai; Lawrence G Hunsicker; Meyeon Park; Michael Bennett; Kathleen D Liu; Chi-Yuan Hsu
Journal:  J Am Soc Nephrol       Date:  2015-11-04       Impact factor: 10.121
  8 in total
  1 in total

Review 1.  [History of epidemics in urology in German-speaking countries].

Authors:  F H Moll; T Halling; M Griemmert
Journal:  Urologe A       Date:  2020-08       Impact factor: 0.803
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.